Tag: adjunct
Phase 2 ProTEct-MS trial confirms safety of higher doses of temelimab and synergistic potential to treat neurodegeneration as an adjunct to anti-inflammatory treatment in multiple sclerosis – 03/21/2022 at 07:00 30
If you wish to receive all of the company’s financial communications in real time, you can register directly by email at the following address: [email protected] Holding of a webinar today,…